Isoform-selective phosphoinositide 3-kinase inhibitors induce apoptosis in chronic lymphocytic leukaemia cells

被引:8
作者
de Frias, Merce [1 ]
Iglesias-Serret, Daniel [1 ]
Cosialls, Ana M. [1 ]
Gonzalez-Girones, Diana M. [1 ]
Perez-Perarnau, Alba [1 ]
Rubio-Patino, Camila [1 ]
Rueckle, Thomas [2 ,3 ]
Camps, Montserrat
Fernandez de Sevilla, Alberto [4 ]
de la Banda, Esmeralda [5 ]
Pons, Gabriel [1 ]
Gil, Joan [1 ]
机构
[1] Univ Barcelona, Inst Invest Biomed Bellvitge, Dept Ciencies Fisiol 2, Barcelona, Spain
[2] Merck Serono SA, Res Ctr Geneva, Dept Chem, Geneva, Switzerland
[3] Merck Serono SA, Res Ctr Geneva, Dept Signal Transduct, Geneva, Switzerland
[4] IDIBELL Inst Catala Oncol, Dept Clin Hematol, Lhospitalet De Llobregat, Spain
[5] Bellvitge Hosp, Serv Hematol, IDIBELL, Barcelona, Spain
关键词
chronic lymphocytic leukaemia; apoptosis; phosphoinositide; 3-kinase; THERAPY;
D O I
10.1111/j.1365-2141.2010.08151.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:108 / 111
页数:4
相关论文
共 10 条
  • [1] Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells
    Barragan, M
    Bellosillo, B
    Campàs, C
    Colomer, D
    Pons, G
    Gil, J
    [J]. BLOOD, 2002, 99 (08) : 2969 - 2976
  • [2] Key role of the p110δ isoforrn of PI3K in B-cell antigen and IL-4 receptor signaling:: comparative analysis of genetic and pharmacologic interference with p110δ function in B cells
    Bilancio, A
    Okkenhaug, K
    Camps, M
    Emery, JL
    Ruckle, T
    Rommel, C
    Vanhaesebroeck, B
    [J]. BLOOD, 2006, 107 (02) : 642 - 650
  • [3] Functional Whole-genome Analysis Identifies Polo-like Kinase 2 and Poliovirus Receptor as Essential for Neuronal Differentiation Upstream of the Negative Regulator αB-crystallin
    Draghetti, Cristina
    Salvat, Catherine
    Zanoguera, Francisca
    Curchod, Marie-Laure
    Vignaud, Chloe
    Peixoto, Helene
    Di Cara, Alessandro
    Fischer, David
    Dhanabal, Mohanraj
    Andreas, Goutopoulos
    Abderrahim, Hadi
    Rommel, Christian
    Camps, Montserrat
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (46) : 32053 - 32065
  • [4] The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
    Engelman, Jeffrey A.
    Luo, Ji
    Cantley, Lewis C.
    [J]. NATURE REVIEWS GENETICS, 2006, 7 (08) : 606 - 619
  • [5] The immunodeficiency of chronic lymphocytic leukaemia
    Hamblin, A. D.
    Hamblin, T. J.
    [J]. BRITISH MEDICAL BULLETIN, 2008, 87 (01) : 49 - 62
  • [6] PI 3-kinase p110β:: a new target for antithrombotic therapy
    Jackson, SP
    Schoenwaelder, SM
    Goncalves, I
    Nesbitt, WS
    Yap, CL
    Wright, CE
    Kenche, V
    Anderson, KE
    Dopheide, SM
    Yuan, YP
    Sturgeon, SA
    Prabaharan, H
    Thompson, PE
    Smith, GD
    Shepherd, PR
    Daniele, N
    Kulkarni, S
    Abbott, B
    Saylik, D
    Jones, C
    Lu, L
    Giuliano, S
    Hughan, SC
    Angus, JA
    Robertson, AD
    Salem, HH
    [J]. NATURE MEDICINE, 2005, 11 (05) : 507 - 514
  • [7] AKT/PKB signaling: Navigating downstream
    Manning, Brendan D.
    Cantley, Lewis C.
    [J]. CELL, 2007, 129 (07) : 1261 - 1274
  • [8] Targeting phosphoinositide 3-kinase - Moving towards therapy
    Marone, Romina
    Cmijanovic, Vladimir
    Giese, Bemd
    Wymann, Matthias P.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2008, 1784 (01): : 159 - 185
  • [9] Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach
    Niedermeier, Matthias
    Hennessy, Bryan T.
    Knight, Zachary A.
    Henneberg, Marina
    Hu, Jianhua
    Kurtova, Antonina V.
    Wierda, William G.
    Keating, Michael J.
    Shokat, Kevan M.
    Burger, Jan A.
    [J]. BLOOD, 2009, 113 (22) : 5549 - 5557
  • [10] Molecular and cellular mechanisms of CLL: novel therapeutic approaches
    Pleyer, Lisa
    Egle, Alexander
    Hartmann, Tanja Nicole
    Greil, Richard
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (07) : 405 - 418